Vizimpro 45 mg/1
dacomitinib · TABLET, FILM COATED · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
Vizimpro is a tablet, film coated containing dacomitinib at 45 mg/1, taken oral. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Vizimpro
- Generic Name
- dacomitinib
- NDC Code (Product)
0069-2299- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 45 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA211288
- Marketing Start
- 10/04/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Vizimpro used for?
Vizimpro contains dacomitinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Vizimpro a controlled substance?
Vizimpro is not classified as a controlled substance by the DEA.
What is the generic name for Vizimpro?
The generic name for Vizimpro is dacomitinib. There are no other listed brand versions of dacomitinib.
What is the NDC code for Vizimpro 45 mg/1?
The NDC (National Drug Code) for Vizimpro 45 mg/1 is 0069-2299, listed by Pfizer Laboratories Div Pfizer Inc.
Other Vizimpro Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)